Mass. pharma company will pay $20.75M to settle FCA lawsuit

Whistleblower

A Massachusetts-based pharmaceutical company will pay $20.75 million settle a whistleblower’s allegations that the company knowingly promoted misleading instructions for a skin lesion drug that caused doctors to submit false claims to Medicare.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.